Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics

Published

Author(s)

Yihua B. Yu, Katharine T. Briggs, Marc B. Taraban, Robert Brinson, John Marino

Abstract

Biologics are complex pharmaceuticals that include formulated proteins, plasma products, vaccines, cell and gene therapy products, and biological tissues. These products are fragile and typically require cold chain for their delivery and storage. Delivering biologics, while maintaining the cold chain, whether standard (2°C to 8°C) or deepfreeze (as cold as -70°C), requires extensive infrastructure that is expensive to build and maintain. This poses a huge challenge to equitable healthcare delivery, especially during a global pandemic. Even when the infrastructure is in place, breaches of the cold chain are common. Such breaches may damage the product, making therapeutics and vaccines ineffective or even harmful. Rather than strengthening the cold chain through building more infrastructure and imposing more stringent guidelines, we suggest that money and effort are best spent on making the cold chain unnecessary for biologics delivery and storage. To meet this grand challenge in pharmaceutical research, we highlight areas where innovations are needed in the design, formulation and biomanufacturing of biologics, including point-of-care manufacturing and inspection. These technological innovations would rely on fundamental advances in our understanding of biomolecules and cells.
Citation
Pharmaceutical Research
Volume
38

Keywords

biologics, cold chain, drug products

Citation

Yu, Y. , Briggs, K. , Taraban, M. , Brinson, R. and Marino, J. (2021), Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics, Pharmaceutical Research, [online], https://doi.org/10.1007/s11095-021-03008-w, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=931571 (Accessed October 10, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created February 8, 2021, Updated October 11, 2022